Ubiquitin Specific Peptidase 22 (USP22) overexpression occurs in several types of highly aggressive human cancers and is associated with a “death from cancer” gene signature for therapy resistance and stem cell like phenotypes [1–3]. Here, USP22 is linked to cancer.